Papers on Alpha-1 Research Published in the COPD Foundation Journal
The latest issue of the Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation (Volume 5, Issue 4 – 2018) features papers from presenters at the “3rd Biennial International Research Conference on Alpha-1 Antitrypsin,” which was sponsored by the Alpha-1 Foundation, and is another example of a non-branded scientific meeting that has as its theme novel treatment paradigms in Alpha-1 Antitrypsin Deficiency (Alpha-1) and selected other conditions.
To obtain the best possible collection of experts taking part in the conference, the steering committee invited Noel G. McElvaney, MD, BCh, BAO, FRCPI, FRCPC, professor of medicine and pulmonary consultant at the Royal College of Surgeons in Ireland, to develop the scientific program, serve as its chair, and in turn, invite 30 experts best suited for individual presentations and as discussants.
“The reason for publishing information exchanged at a scientific meeting is to make the proceedings available to a wider audience than the meeting participants, irrespective of the stated purpose of the conference,” wrote in the editorial of the Journal Adam Wanner, MD, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Miami, Miller School of Medicine, Miami, Florida, and scientific director of the Alpha-1 Foundation. “These stated purposes may range from establishing, at a given point in time, the biologic basis of disease, to education on disease diagnosis and management for clinicians, to the promotion of new diagnostics and therapies,” he added.
Source: the Alpha-1 Foundation